Regeneron Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Regeneron Pharmaceuticals patents 453 in total
Status | Patent |
---|---|
Application | Utility: METHODS AND SYSTEMS FOR SPARSE VECTOR-BASED MATRIX TRANSFORMATIONS Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: Methods for Treating Skin Infection by Administering an IL-4R Antagonist Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VEGF Filling date: 13 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: Human Antibodies to Middle East Respiratory Syndrome - Coronavirus Spike Protein Filling date: 13 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: HIGH CONCENTRATION VEGF RECEPTOR FUSION PROTEIN CONTAINING FORMULATIONS Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: SYSTEMS AND METHODS FOR QUANTIFYING AND MODIFYING PROTEIN VISCOSITY Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: HUMANIZED IL-7 RODENTS Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: METHODS FOR EVALUATING SUITABILITY OF A BIOCHEMICAL FILTER Filling date: 13 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function Mutations Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: MEDICAL IMAGING TABLE, TABLE SUPPORT ASSEMBLY, PROBE SUPPORT ASSEMBLY, SYSTEM, AND METHOD OF USE Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: TARGETED MODIFICATION OF RAT GENOME Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3 Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: GENETIC MODIFICATION OF RATS Filling date: 13 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: METHODS OF TREATMENT USING A LEPTIN RECEPTOR AGONIST ANTIBODY Filling date: 13 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: Genetically Modified Mice and Engraftment Filling date: 13 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS Filling date: 13 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: SYSTEMS AND METHODS FOR IDENTIFYING HLA-ASSOCIATED TUMOR PEPTIDES Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: METHODS FOR REDUCING CARDIOVASCULAR RISK Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: ASSEMBLY LINE WITH INTEGRATED ELECTRONIC VISUAL INSPECTION Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: ANTI-LAG3 ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: STABILIZED FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES Filling date: 13 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS Filling date: 13 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: MICROCHIP CAPILLARY ELECTROPHORESIS ASSAYS AND REAGENTS Filling date: 13 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: Anti-TIE2 Antibodies and Uses Thereof Filling date: 13 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: METHODS FOR ALTERING BODY COMPOSITION Filling date: 13 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: PRODUCTION CELL LINE ENHANCERS Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION Filling date: 13 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: SYSTEMS AND METHODS FOR IDENTIFYING VIRAL CONTAMINANTS Filling date: 13 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: Restricted Immunoglobulin Heavy Chain Mice Filling date: 13 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: COMPOSITIONS AND METHODS FOR MAKING ANTIBODIES BASED ON USE OF AN EXPRESSION-ENHANCING LOCUS Filling date: 13 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: GAN-CNN FOR MHC PEPTIDE BINDING PREDICTION Filling date: 13 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: HIGH AFFINITY ANTIBODIES TO HUMAN IL-6 RECEPTOR Filling date: 13 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 13 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: SYSTEMS AND METHODS FOR FAILURE MODE DETECTION IN PROCESS CHROMATOGRAPHY Filling date: 13 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: METHODS OF LOWERING BLOOD GLUCOSE LEVELS Filling date: 13 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: SYSTEM AND METHOD FOR CHARACTERIZING PROTEIN DIMERIZATION Filling date: 13 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE Filling date: 13 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE Filling date: 13 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: ANTI-PRLR ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMULATION Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: Quantitation and Modeling of Quality Attributes of Therapeutic Monoclonal Antibodies Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: GLUCURONYLATION AS A NEW ACIDIC POST-TRANSLATIONAL MODIFICATION ON THERAPEUTIC MONOCLONAL ANTIBODIES Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Showing 400 to 450 of 453 patents.